Department of Head and Neck Surgery, University of Sao Paulo Medical School (LIM 28); Attending Surgeon, Instituto do Câncer do Estado de São Paulo (ICESP), Brazil.
Department of Head and Neck Surgery of Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Brazil.
Oral Oncol. 2017 Aug;71:47-53. doi: 10.1016/j.oraloncology.2017.05.020. Epub 2017 Jun 6.
To evaluate the new American Joint Committee on Cancer (AJCC) cancer staging manual (8th edition) in an independent cohort of patients surgically treated for oral squamous cell carcinoma in order to determine whether the upstaging of pT and pN classification was indicative of a worse prognosis.
A cohort of 298 patients was analyzed retrospectively.
Of these patients, 22.8% received an upstaging when the depth of invasion was included into the pT classification. Similarly, 29.2% of them were upstaged when extracapsular extension was added to pN classification. Twenty-eight of 68 patients (41.2%) that received an upstaging of pT classification died, and 23 (33.8%) experienced disease recurrence compared to 98/229 (42.8%) and 68/229 (29.7%), respectively, for those with the same pT during follow-up. With regard to pN classification, 70.6% of upstaged patients (60/85) died, and 50.6% (43/85) developed recurrence of the disease compared to 63/205 (30.7%) and 42/205 (20.5%), respectively, for those with the same pN during follow-up. Patients who were upstaged in pT classification presented a worse DFS (51.1% versus 80.4%, P=0.007) and OS (31.5% versus 58.6%, P=0.017). Similarly, those that were upstaged in pN classification presented a worse DFS (17.1% versus 61.2%, P=0.001) and OS (8.5% versus 37.9%, P<0.001).
The new AJCC cancer staging manual (8th edition) allows a better stratification of oral SCC patients. By including the depth of invasion to the pT classification and extranodal extension to the pN classification, a worse disease-free and overall survival was assessed for these patients.
评估新的美国癌症联合委员会(AJCC)癌症分期手册(第 8 版)在接受口腔鳞状细胞癌手术治疗的独立患者队列中的应用,以确定 pT 和 pN 分类的升级是否预示着预后更差。
回顾性分析了 298 例患者的队列。
这些患者中,22.8%的患者在纳入 pT 分类的侵袭深度时被升级分期。同样,29.2%的患者在外囊扩展纳入 pN 分类时被升级分期。68 例 pT 分类升级患者中有 28 例(41.2%)死亡,23 例(33.8%)发生疾病复发,而在随访中 pT 分期相同的 229 例患者中,分别有 98/229(42.8%)和 68/229(29.7%)发生疾病复发。对于 pN 分类,85 例升级患者中有 70.6%(60/85)死亡,50.6%(43/85)发生疾病复发,而在随访中 pN 分期相同的 205 例患者中,分别有 63/205(30.7%)和 42/205(20.5%)发生疾病复发。pT 分类升级的患者 DFS(51.1%对 80.4%,P=0.007)和 OS(31.5%对 58.6%,P=0.017)较差。同样,pN 分类升级的患者 DFS(17.1%对 61.2%,P=0.001)和 OS(8.5%对 37.9%,P<0.001)较差。
新的 AJCC 癌症分期手册(第 8 版)允许更好地对口腔 SCC 患者进行分层。通过将侵袭深度纳入 pT 分类和淋巴结外扩展纳入 pN 分类,这些患者的无病生存率和总生存率评估较差。